By Jim Schnabel Weill Cornell Medicine Ithaca, November 3, 2022.- Innate lymphoid cells are a recently discovered family of white blood cells that reside in the skin, gastrointestinal tract, airways and other barrier tissues of the body. Group 2 innate lymphoid cells (ILC2s) have an essential role in protecting theseContinuar Leyendo
Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new research. Ithaca, NY, October 31, 2022.- The paper, «Evolution and Antiviral Activity of a Human Protein of Retroviral Origin,» published Oct. 28 in Science, provides proofContinuar Leyendo
Researchers at University of California San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery, published in the October 26, 2022 issue of Nature, opens the possibility of new therapies, including for multiple forms ofContinuar Leyendo
It’s the vitamin that we get from the sun, yet despite its ample availability, one in three Australian adults still suffer from mild, moderate or severe vitamin D deficiency. South Australia, October 26, 2022.- Now, new research from the University of South Australia gives strong evidence that vitamin D deficiencyContinuar Leyendo
Cambridge scientists have shown that it is possible to spot signs of brain impairment in patients as early as nine years before they receive a diagnosis for one of a number of dementia-related diseases. Cambrigde, October 26, 2022.- In research published today in Alzheimer’s & Dementia: The Journal of theContinuar Leyendo
Getting less than five hours of sleep in mid-to-late life could be linked to an increased risk of developing at least two chronic diseases, finds a new study led by UCL researchers. London, October 22, 2022.- The research, published in PLOS Medicine, analysed the impact of sleep duration on theContinuar Leyendo
Researchers of the University of Bern and the Insel Hospital, University Hospital Bern, have developed a screening method to discover new drug targets for cancer treatment in the socalled “Dark Matter” of the genome. They applied their method to non-small cell lung cancer (NSCLC), the greatest cancer killer for whichContinuar Leyendo
A mutation in the small protein SHMOOSE is associated with Alzheimer’s risk and highlights a possible target for treatment Los Angeles, Sept 21, 2022.- A mutation in a newly discovered small protein is connected to a significant increase in the risk for Alzheimer’s disease, expanding the known gene targets forContinuar Leyendo
New research in mice pinpoints disease-modifying molecules produced by astrocytes in Rett, fragile X and Down syndromes La Jolla, Sept 19, 2022.- Neurons often get most of the credit for keeping our brains sharp and functioning—as well as most of the blame when it comes to brain diseases. But star-shapedContinuar Leyendo
By Jim Schnabel New York, August 31, 2022.- The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart’s rhythmic beat, setting off a self-destruction process within the cells, according to a preclinical study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and NYU Grossman School of Medicine. TheContinuar Leyendo
